124 related articles for article (PubMed ID: 9032943)
1. Nitroxide reduction with ascorbic acid in spin labeled human plasma LDL and VLDL.
Kveder M; Pifat G; Pecar S; Schara M; Ramos P; Esterbauer H
Chem Phys Lipids; 1997 Jan; 85(1):1-12. PubMed ID: 9032943
[TBL] [Abstract][Full Text] [Related]
2. The interaction of lower alcohols with apoB in spin labeled human plasma low density lipoproteins (LDL).
Kveder M; Pifat G; Pecar S; Schara M; Ramos P; Esterbauer H
Chem Phys Lipids; 1997 Jul; 87(2):125-35. PubMed ID: 9275308
[TBL] [Abstract][Full Text] [Related]
3. The ESR characterization of molecular mobility in the lipid surface layer of human serum lipoproteins.
Kveder M; Pifat G; Pecar S; Schara M
Chem Phys Lipids; 1994 Mar; 70(1):101-8. PubMed ID: 8013052
[TBL] [Abstract][Full Text] [Related]
4. Decreased susceptibility to copper-induced oxidation of rat-lipoproteins after fibrate treatment: influence of fatty acid composition.
Vázquez M; Merlos M; Adzet T; Laguna JC
Br J Pharmacol; 1996 Mar; 117(6):1155-62. PubMed ID: 8882610
[TBL] [Abstract][Full Text] [Related]
5. [Effect of fibrates on VLDL and LDL lipoprotein composition and parameters of their oxidation in hypertriglyceridemia].
Zeman M; Zák A; Tvrzická E; Konárková M; Stípek S
Cas Lek Cesk; 2002 Apr; 141(7):211-6. PubMed ID: 12053756
[TBL] [Abstract][Full Text] [Related]
6. Alterations in the physiochemical characteristics of low and high density lipoproteins after lipolysis with phospholipase A2. A spin-label study.
Gorshkova IN; Menschikowski M; Jaross W
Biochim Biophys Acta; 1996 Apr; 1300(2):103-13. PubMed ID: 8652635
[TBL] [Abstract][Full Text] [Related]
7. Binding of spin-labeled clofibrate to lipoproteins.
Olivier JL; Chachaty C; Wolf C; Salmon S; Bereziat G
Biochim Biophys Acta; 1988 Dec; 963(3):515-24. PubMed ID: 2848587
[TBL] [Abstract][Full Text] [Related]
8. [Plasma lipoproteins of the preruminant calf].
Bauchart D; Levieux D
Reprod Nutr Dev (1980); 1985; 25(1B):243-50. PubMed ID: 3991994
[TBL] [Abstract][Full Text] [Related]
9. [Fatty acid composition and parameters of VLDL and LDL in persons with dyslipidemia].
Zák A; Zeman M; Tvrzická E; Stípek S; Buchtíková M; Pousek L; Nováková E
Cas Lek Cesk; 2000 Jan; 139(1):18-23. PubMed ID: 10750287
[TBL] [Abstract][Full Text] [Related]
10. Vegetable oils affect the composition of lipoproteins in sea bream (Sparus aurata).
Caballero MJ; Torstensen BE; Robaina L; Montero D; Izquierdo M
Br J Nutr; 2006 Nov; 96(5):830-9. PubMed ID: 17092370
[TBL] [Abstract][Full Text] [Related]
11. A randomized, single-blind, placebo-controlled trial of the effects of 200 mg alpha-tocopherol on the oxidation resistance of atherogenic lipoproteins.
Porkkala-Sarataho EK; Nyyssönen MK; Kaikkonen JE; Poulsen HE; Hayn EM; Salonen RM; Salonen JT
Am J Clin Nutr; 1998 Nov; 68(5):1034-41. PubMed ID: 9808219
[TBL] [Abstract][Full Text] [Related]
12. Effect of chronic ethanol feeding on the hepatic secretion of very-low-density lipoproteins.
Venkatesan S; Ward RJ; Peters TJ
Biochim Biophys Acta; 1988 May; 960(1):61-6. PubMed ID: 3358946
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein composition and oxidative modification during therapy with gemfibrozil and lovastatin in patients with combined hyperlipidaemia.
Vázquez M; Zambón D; Hernández Y; Adzet T; Merlos M; Ros E; Laguna JC
Br J Clin Pharmacol; 1998 Mar; 45(3):265-9. PubMed ID: 9517370
[TBL] [Abstract][Full Text] [Related]
14. [Structural characteristics of plasma lipoproteins studied with spin-labelled fatty acids].
Artemova LG; Torkhovskaia TI; Shcherbakova IA; Chernyshova NP; Suchkova SN
Vopr Med Khim; 1979; 25(6):758-65. PubMed ID: 229636
[TBL] [Abstract][Full Text] [Related]
15. [Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)].
Weisweiler P; Schwandt P
Klin Wochenschr; 1977 Aug; 55(16):791-4. PubMed ID: 198601
[TBL] [Abstract][Full Text] [Related]
16. [Insulinemia, fatty acids in plasma lipids and lipoproteins and oxidation of VLDL and LDL in hyperlipidemia].
Zeman M; Zák A; Tvrzická E; Buchtíková M; Stípek S; Pousek L
Sb Lek; 2000; 101(1):77-82. PubMed ID: 10953635
[TBL] [Abstract][Full Text] [Related]
17. Plasmalogen oxidation in human serum lipoproteins.
Felde R; Spiteller G
Chem Phys Lipids; 1995 Jun; 76(2):259-67. PubMed ID: 7634364
[TBL] [Abstract][Full Text] [Related]
18. Effect of cholesterol feeding on the susceptibility of lipoproteins to oxidative modification.
Nenseter MS; Gudmundsen O; Malterud KE; Berg T; Drevon CA
Biochim Biophys Acta; 1994 Jul; 1213(2):207-14. PubMed ID: 8025132
[TBL] [Abstract][Full Text] [Related]
19. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
[TBL] [Abstract][Full Text] [Related]
20. Interaction of lipoproteins with type II pneumocytes in vitro: morphological studies, uptake kinetics and secretion rate of cholesterol.
Guthmann F; Harrach-Ruprecht B; Looman AC; Stevens PA; Robenek H; Rüstow B
Eur J Cell Biol; 1997 Oct; 74(2):197-207. PubMed ID: 9352225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
